|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,155.00 NGN | 0.00% |
|
0.00% | +89.66% |
| Jun. 12 | Speculative Fever Grips the Nigerian Stock Market | |
| May. 13 | Dangote Cement in early talks over potential London listing | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 16.51 | 14.62 | 13.95 | 13.72 | 17.64 | |||||
Return on Total Capital | 24.56 | 21.62 | 19.99 | 18.68 | 25.38 | |||||
Return On Equity % | 38.88 | 37.07 | 32.49 | 25.8 | 42.33 | |||||
Return on Common Equity | 39.21 | 37.23 | 32.43 | 26.13 | 43.2 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 60.07 | 58.94 | 54.29 | 53.88 | 61.89 | |||||
SG&A Margin | 18.3 | 22.96 | 22.1 | 23.25 | 21.75 | |||||
EBITDA Margin % | 49.26 | 43.49 | 39.77 | 37.91 | 45.6 | |||||
EBITA Margin % | 42.13 | 36.2 | 33.12 | 31.71 | 40.78 | |||||
EBIT Margin % | 42.13 | 36.2 | 33.12 | 31.71 | 40.78 | |||||
Income From Continuing Operations Margin % | 26.34 | 23.62 | 20.63 | 14.06 | 23.57 | |||||
Net Income Margin % | 26.09 | 23.23 | 20.16 | 13.91 | 23.29 | |||||
Net Avail. For Common Margin % | 26.09 | 23.23 | 20.16 | 13.91 | 23.29 | |||||
Normalized Net Income Margin | 24.09 | 19.84 | 15.1 | 12.36 | 21.83 | |||||
Levered Free Cash Flow Margin | 23.26 | 6.97 | 23.19 | 1.96 | 13.95 | |||||
Unlevered Free Cash Flow Margin | 25.8 | 9.88 | 27.28 | 9.78 | 18.98 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.63 | 0.65 | 0.67 | 0.69 | 0.69 | |||||
Fixed Assets Turnover | 0.96 | 1.06 | 1.11 | 1.24 | 1.18 | |||||
Receivables Turnover (Average Receivables) | 9.81 | 9.5 | 9.04 | 9.92 | 9.3 | |||||
Inventory Turnover (Average Inventory) | 2.68 | 3.01 | 2.94 | 2.79 | 2.09 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.81 | 1 | 0.87 | 0.74 | 0.76 | |||||
Quick Ratio | 0.5 | 0.48 | 0.5 | 0.37 | 0.38 | |||||
Operating Cash Flow to Current Liabilities | 0.55 | 0.38 | 0.42 | 0.32 | 0.66 | |||||
Days Sales Outstanding (Average Receivables) | 37.22 | 38.43 | 40.37 | 36.9 | 39.26 | |||||
Days Outstanding Inventory (Average Inventory) | 135.96 | 121.42 | 124.17 | 131.26 | 174.56 | |||||
Average Days Payable Outstanding | 105.91 | 110.42 | 87.61 | 85.54 | 122.59 | |||||
Cash Conversion Cycle (Average Days) | 67.27 | 49.43 | 76.94 | 82.62 | 91.23 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 59.79 | 68.18 | 59.87 | 122.46 | 45.43 | |||||
Total Debt / Total Capital | 37.42 | 40.54 | 37.45 | 55.05 | 31.24 | |||||
LT Debt/Equity | 18.76 | 31.66 | 23.46 | 64.94 | 14.67 | |||||
Long-Term Debt / Total Capital | 11.74 | 18.82 | 14.67 | 29.19 | 10.09 | |||||
Total Liabilities / Total Assets | 58.88 | 58.75 | 56.18 | 66.03 | 56.63 | |||||
EBIT / Interest Expense | 10.35 | 7.79 | 5.06 | 2.53 | 5.07 | |||||
EBITDA / Interest Expense | 12.13 | 9.38 | 6.1 | 3.04 | 5.69 | |||||
(EBITDA - Capex) / Interest Expense | 9.32 | 8.39 | 5.13 | 2.1 | 3.21 | |||||
Total Debt / EBITDA | 0.86 | 1.04 | 1.17 | 1.95 | 0.6 | |||||
Net Debt / EBITDA | 0.36 | 0.64 | 0.66 | 1.62 | 0.4 | |||||
Total Debt / (EBITDA - Capex) | 1.12 | 1.17 | 1.39 | 2.83 | 1.07 | |||||
Net Debt / (EBITDA - Capex) | 0.47 | 0.72 | 0.79 | 2.35 | 0.71 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 33.79 | 16.96 | 36.44 | 62.16 | 20.28 | |||||
Gross Profit, 1 Yr. Growth % | 39.72 | 14.75 | 25.68 | 60.92 | 38.16 | |||||
EBITDA, 1 Yr. Growth % | 43.54 | 3.26 | 24.79 | 54.57 | 45.86 | |||||
EBITA, 1 Yr. Growth % | 51.16 | 0.49 | 24.85 | 55.25 | 56.17 | |||||
EBIT, 1 Yr. Growth % | 51.16 | 0.49 | 24.85 | 55.25 | 56.17 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 32.01 | 4.9 | 19.17 | 10.46 | 101.67 | |||||
Net Income, 1 Yr. Growth % | 31.24 | 4.15 | 18.41 | 11.9 | 101.3 | |||||
Normalized Net Income, 1 Yr. Growth % | 43.89 | -3.66 | 3.85 | 32.66 | 115.82 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 31.55 | 4.89 | 18.85 | 12.34 | 101.3 | |||||
Accounts Receivable, 1 Yr. Growth % | 23.84 | 18.31 | 64.48 | 37.68 | 21.5 | |||||
Inventory, 1 Yr. Growth % | 87.56 | 39.94 | 66.33 | 76.2 | 7.77 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.28 | 3.98 | 57 | 37.25 | 19.08 | |||||
Total Assets, 1 Yr. Growth % | 18.27 | 9.35 | 50.58 | 62.57 | -5.66 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.2 | 9.15 | 60.16 | 25.4 | 18.95 | |||||
Common Equity, 1 Yr. Growth % | 10.21 | 9.22 | 60.38 | 25.49 | 18.76 | |||||
Cash From Operations, 1 Yr. Growth % | 16.57 | -35 | 75.02 | 20.96 | 108.33 | |||||
Capital Expenditures, 1 Yr. Growth % | -24.65 | -52.93 | 87.93 | 201.7 | 108.1 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 234.24 | -64.94 | 353.71 | -86.28 | 726.09 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 188.47 | -55.22 | 276.75 | -41.84 | 131.67 | |||||
Dividend Per Share, 1 Yr. Growth % | 25 | 0 | 50 | 0 | 50 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 24.57 | 25.09 | 26.33 | 48.74 | 39.66 | |||||
Gross Profit, 2 Yr. CAGR % | 27.65 | 26.63 | 20.1 | 42.22 | 49.11 | |||||
EBITDA, 2 Yr. CAGR % | 31.75 | 21.75 | 13.51 | 38.88 | 49.55 | |||||
EBITA, 2 Yr. CAGR % | 39.55 | 23.25 | 12.01 | 39.22 | 54.97 | |||||
EBIT, 2 Yr. CAGR % | 39.55 | 23.25 | 12.01 | 39.22 | 54.97 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 34.81 | 17.68 | 11.81 | 14.73 | 49.26 | |||||
Net Income, 2 Yr. CAGR % | 34.04 | 16.91 | 11.05 | 15.11 | 50.08 | |||||
Normalized Net Income, 2 Yr. CAGR % | 45.88 | 17.74 | 0.03 | 17.38 | 67.91 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 34.2 | 17.46 | 11.65 | 15.55 | 50.38 | |||||
Accounts Receivable, 2 Yr. CAGR % | 21.45 | 21.04 | 39.5 | 50.49 | 29.34 | |||||
Inventory, 2 Yr. CAGR % | 43.78 | 34.22 | 52.56 | 71.19 | 37.8 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.62 | 5.13 | 27.77 | 46.79 | 27.84 | |||||
Total Assets, 2 Yr. CAGR % | 17.17 | 13.72 | 28.32 | 56.46 | 23.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | 4.28 | 9.67 | 32.22 | 41.72 | 22.13 | |||||
Common Equity, 2 Yr. CAGR % | 4.35 | 9.71 | 32.35 | 41.87 | 22.08 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.34 | -12.96 | 6.66 | 45.5 | 58.76 | |||||
Capital Expenditures, 2 Yr. CAGR % | -5.38 | -40.45 | -5.95 | 138.11 | 147.81 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 46.29 | 8.26 | 26.13 | -21.11 | 8.34 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 41.72 | 13.65 | 29.89 | 48.02 | 16.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 11.8 | 22.47 | 22.47 | 22.47 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.36 | 21.98 | 28.77 | 37.29 | 38.58 | |||||
Gross Profit, 3 Yr. CAGR % | 17.19 | 23.2 | 26.31 | 32.4 | 40.85 | |||||
EBITDA, 3 Yr. CAGR % | 16.26 | 21.47 | 22.75 | 25.82 | 40.79 | |||||
EBITA, 3 Yr. CAGR % | 19.91 | 25.08 | 23.78 | 24.89 | 44.2 | |||||
EBIT, 3 Yr. CAGR % | 19.91 | 25.08 | 23.78 | 24.89 | 44.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -2.26 | 24 | 18.17 | 11.36 | 38.46 | |||||
Net Income, 3 Yr. CAGR % | -2.46 | 23.23 | 17.41 | 11.33 | 38.68 | |||||
Normalized Net Income, 3 Yr. CAGR % | 21.41 | 27.04 | 12.92 | 9.9 | 43.06 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -2.38 | 23.62 | 17.92 | 11.88 | 39.03 | |||||
Accounts Receivable, 3 Yr. CAGR % | 23.37 | 20.39 | 34.07 | 38.89 | 40.13 | |||||
Inventory, 3 Yr. CAGR % | 32.46 | 25.69 | 44.17 | 60.07 | 46.72 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.37 | 8.37 | 20.16 | 30.86 | 36.9 | |||||
Total Assets, 3 Yr. CAGR % | 12.18 | 14.5 | 24.88 | 38.85 | 32.18 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.31 | 5.88 | 24.43 | 29.9 | 33.68 | |||||
Common Equity, 3 Yr. CAGR % | -0.33 | 5.95 | 24.52 | 30.02 | 33.71 | |||||
Cash From Operations, 3 Yr. CAGR % | 16.71 | -3.09 | 9.86 | 11.23 | 64 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.55 | -25.03 | -12.65 | 38.71 | 125.98 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 121.96 | -9.13 | 74.54 | -39.8 | 74.63 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 86.19 | -3.48 | 69.46 | -0.63 | 72.27 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.72 | 7.72 | 23.31 | 14.47 | 31.04 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.6 | 14.97 | 19.63 | 32.05 | 33.02 | |||||
Gross Profit, 5 Yr. CAGR % | 23.42 | 16.05 | 18.35 | 30.48 | 34.98 | |||||
EBITDA, 5 Yr. CAGR % | 21.69 | 12.67 | 15.15 | 28.16 | 32.84 | |||||
EBITA, 5 Yr. CAGR % | 26.33 | 14.01 | 16.69 | 30.56 | 35.42 | |||||
EBIT, 5 Yr. CAGR % | 26.33 | 14.01 | 16.69 | 30.56 | 35.42 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 20.6 | 13.36 | 3.14 | 20.21 | 29.74 | |||||
Net Income, 5 Yr. CAGR % | 19.28 | 13.62 | 2.74 | 19.91 | 29.53 | |||||
Normalized Net Income, 5 Yr. CAGR % | 22.89 | 12.88 | 12.35 | 23.08 | 32.34 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 19.33 | 13.83 | 3.01 | 20.32 | 29.97 | |||||
Accounts Receivable, 5 Yr. CAGR % | 35.23 | 14.59 | 29.58 | 31.63 | 32.16 | |||||
Inventory, 5 Yr. CAGR % | 26.49 | 20.8 | 30 | 42.23 | 41.59 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.23 | 5.4 | 15.75 | 22.35 | 23.18 | |||||
Total Assets, 5 Yr. CAGR % | 9.36 | 9.44 | 18.38 | 29.73 | 24.46 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.51 | 6.57 | 11.61 | 18.98 | 23.5 | |||||
Common Equity, 5 Yr. CAGR % | 5.51 | 6.52 | 11.64 | 19.07 | 23.54 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.46 | 2.35 | 12.58 | 14.02 | 27.29 | |||||
Capital Expenditures, 5 Yr. CAGR % | 5.93 | -7.12 | 1.36 | 19.03 | 32.56 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 19.88 | -5.23 | 77.05 | -14.13 | 44.23 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 17.68 | -2.36 | 61.21 | 14.53 | 45.87 | |||||
Dividend Per Share, 5 Yr. CAGR % | 18.66 | 13.75 | 13.4 | 13.4 | 22.98 |
- Stock Market
- Stocks
- DANGCEM Stock
- Financials Dangote Cement Plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















